Viewing Study NCT06649552



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06649552
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-16

Brief Title: French Validation of Schizophrenia Proneness Instrument- Child Youth
Sponsor: None
Organization: None

Study Overview

Official Title: French Validation of Schizophrenia Proneness Instrument- Child Youth
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SPI-CY-Fr
Brief Summary: The clinical concept of a at risk mental state of developing psychosis is based on the identification of attenuated psychotic symptoms during the prodromal phase of psychoses Schmidt et al 2015 Early detection and support of these symptoms can delay the risk of transition to a first psychotic episode van der Gaag van den Berg Ising 2019

The Basic Symptom approach enables detection at the earliest stage of the prodromal phase It postulates that subtle subjective manifestations predating attenuated psychotic symptoms are present very early in the prodromal phase of psychosis and also have predictive value for the risk of developing psychosis F Schultze-Lutter 2009 Basic symptoms are assessed using the Schizophrenia Proneness Instrument available in an adult SPI-A and childadolescent SPI-CY version These scales are part of the international recommendations for the assessment of patients with a Clinical State at High Risk of Psychosis CHR-P Schmidt et al 2015 F Schultze-Lutter et al 2015 The SPI-A is validated in French under the name Outil dEvaluation du Risque Schizophrénique version adulte OERS-A Schultze-Lutter et al 2007 French translation by JR Teyssier with the collaboration of F Gamma and P Loulergue but no French version of the SPI-CY has yet been validated

In collaboration with Dr Frauke Schultze-Lutter the investigators have recently published a French translation of the SPI-CY Schizophrenia Predisposition Instrument - Version for Children and Adolescents F Schultze-Lutter M Marshall E Koch 2021 French translation by F Bernardin and C Dondé This French translation must now be validated to ensure the inter-rater fidelity of the interview

We therefore propose to study the inter-rater reliability of the French version of the SPI-CY by comparing ratings between clinicians who have undergone training in basic symptoms and in administering the SPI-A and SPI-CY tools by Dr Schultze-Lutter This validation will be carried out by comparing on the one hand the rating of the SPI-CY by a clinician A who has administered it to the patient and on the other hand the blind rating of a clinician B on the basis of the interview recorded by clinician A with his patient

The investigators will also explore the links between the SPI-CY and other clinical scales such as the Multisensory Hallucination SCale MHASC Demeulemeester et al 2015 the Prodromal Questionnaire 16 PQ-16 Lejuste et al 2021 the Audiograph Giersch Huard Park Rosen 2021 and the Perceptual and Cognitive Aberrations PCA McDonald et al 2019
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None